VanEck ChiNext ETF
|
- Description
- Performance
- Comps
- Fundamentals
- Valuation
- Rating
CNXT tracks the ChiNext Index, which includes the 100 largest and most liquid stocks listed and trading on the ChiNext Market of the Shenzhen Stock Exchange. The ChiNext Index is comprised of China A-shares. |
Category | Emerging Market Equities |
Fund Sponsor | Van Eck Associates |
Website | www.vaneck.com |
Inception date | Jul 23, 2014 |
Assets (mns) | $15 |
Currency | USD |
Expense ratio | 65 bp |
Distributions | Annually |
Regulation | Open-End Investment Company |
Custodian | Bank of New York Mellon |
Weighting | Market Cap |
Index replication | Full |
Uses derivatives | No |
Options available | Yes |
No. of constituents | 101 |
Wgt avg mkt cap (mns) | $1,317 |
Large cap (>$10bn) | 22.5% |
Mid cap ($2-10bn) | 71.1% |
Small cap (<$2bn) | 6.4% |
Developed mkts | 0.0% |
Emerging mkts | 100.0% |
CONTEMPORARY AMPEREX TECHNOLOGY CO | 81.9 % |
AIER EYE HOSPITAL GROUP CO., LTD. | 2.1 % |
CHONGQING ZHIFEI BIOLOGICAL PRODUC | 1.9 % |
EOPTOLINK TECHNOLOGY INC., LTD. CL | 1.7 % |
MAXSCEND MICROELECTRONICS COMPANY | 1.3 % |
HITHINK ROYALFLUSH INFORMATION NET | 1.0 % |
WALVAX BIOTECHNOLOGY CO., LTD. CLA | 1.0 % |
SHENZHEN NEW INDUSTRIES BIOMEDICAL | 0.9 % |
ISOFTSTONE INFORMATION TECHNOLOGY | 0.8 % |
BEIJING EASPRING MATERIAL TECHNOLO | 0.7 % | Total | 93.2 % |
---|
CHINA | 18.7 % |
HISTORICAL PERFORMANCE
Custom date range | Compare to | ||
thru |
Year-to-date | 1 year | 5 years | 10 years | Since Incep. |
-6.0% | -28.1% | -2.7% | -- | -0.3% |
versus... | Beta | R-squared |
S&P500 | 0.48 | 9% |
MSCI EAFE | 0.62 | 14% |
MSCI Emg. Mkts. | 0.82 | 25% |
Recent close | $22.37 |
30d moving avg. | $24.96 |
Annualized volatility | 28.8% |
Short interest (ETF) | 3.1% |
Relative strength (RSI) | 45 |
Avg. volume (thou.) | 4 |
Turnover | 0.6% |
Bid/Ask (% of price) | 0.26% |
ADV underlying (mns) | $1,872 |
FINDING ALTERNATIVE FUNDS
Below is a list of 46 potential alternatives to the VanEck ChiNext ETF ETF based on the alternatives' overlap in portfolio holdings with CNXT. Consider funds with lower expense ratios and/or higher ALTAR Score™ ratings as possible alternatives.
Benchmark ticker: | CNXT | Expense: | 65 bp | ALTAR Score™: | 4.3% |
Ticker | Fund Name |
Overlap1 vs CNXT (%) |
Expense ratio (bp) |
Savings vs CNXT (bp) |
ALTAR Score™ (%) |
ALTAR vs CNXT (%) |
ASHS | Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF | 1.4 | 65 | 0 | 6.3 | +2.0 |
CQQQ | Invesco China Technology ETF | 0.7 | 70 | -5 | -5.7 | -10.0 |
BKEM | BNY Mellon Emerging Markets Equity ETF | 0.6 | 11 | 54 | 7.7 | +3.4 |
RAYS | Global X Solar ETF | 0.5 | 51 | 14 | 4.7 | +0.4 |
GMET | VanEck Green Metals ETF | 0.4 | 63 | 2 | 10.1 | +5.8 |
CNYA | iShares MSCI China A ETF | 0.4 | 60 | 5 | 8.7 | +4.4 |
DMAT | Global X Disruptive Materials ETF | 0.4 | 59 | 6 | 10.1 | +5.8 |
WBAT | WisdomTree Battery Value Chain and Innovation Fund | 0.3 | 45 | 20 | 4.9 | +0.6 |
KARS | KraneShares Electric Vehicles & Future Mobility Index ETF | 0.2 | 72 | -7 | 2.2 | -2.1 |
ICLN | iShares Global Clean Energy ETF | 0.2 | 41 | 24 | 4.3 | -0.0 |
GXC | SPDR S&P China ETF | 0.2 | 59 | 6 | 9.1 | +4.8 |
TCHI | iShares MSCI China Multisector Tech ETF | 0.1 | 59 | 6 | 3.1 | -1.3 |
SCHE | Schwab Emerging Markets Equity ETF | 0.1 | 11 | 54 | 7.6 | +3.3 |
MCHI | iShares MSCI China ETF | 0.1 | 59 | 6 | 9.0 | +4.7 |
JEMA | JPMorgan ActiveBuilders Emerging Markets Equity ETF | 0.1 | 33 | 32 | 7.2 | +2.9 |
GMF | SPDR S&P Emerging Asia Pacific ETF | 0.1 | 49 | 16 | 6.4 | +2.1 |
ERTH | Invesco MSCI Sustainable Future ETF | 0.1 | 62 | 3 | 3.7 | -0.6 |
FLCH | Franklin FTSE China ETF | 0.0 | 19 | 46 | 9.6 | +5.3 |
EMCR | Xtrackers Emerging Markets Carbon Reduction and Climate Impr | 0.0 | 15 | 50 | 7.1 | +2.8 |
DFSE | Dimensional Emerging Markets Sustainability Core 1 ETF | 0.0 | 41 | 24 | 7.8 | +3.5 |
BKF | iShares MSCI BIC ETF | 0.0 | 69 | -4 | 7.1 | +2.8 |
GCLN | Goldman Sachs Bloomberg Clean Energy Equity ETF | 0.0 | 45 | 20 | 6.3 | +1.9 |
VSS | Vanguard FTSE All-World ex-US Small-Cap ETF | 0.0 | 7 | 58 | 6.5 | +2.2 |
DFAE | Dimensional Emerging Core Equity Market ETF | 0.0 | 35 | 30 | 7.7 | +3.4 |
SPEM | SPDR Portfolio Emerging Markets ETF | 0.0 | 7 | 58 | 7.5 | +3.2 |
AAXJ | iShares MSCI All Country Asia ex Japan ETF | 0.0 | 70 | -5 | 6.3 | +2.0 |
DFEM | Dimensional Emerging Markets Core Equity 2 ETF | 0.0 | 38 | 27 | 8.3 | +3.9 |
EEMA | iShares MSCI Emerging Markets Asia ETF | 0.0 | 49 | 16 | 6.7 | +2.4 |
VWO | Vanguard FTSE Emerging Markets ETF | 0.0 | 8 | 57 | 7.6 | +3.3 |
DEHP | Dimensional Emerging Markets High Profitability ETF | 0.0 | 41 | 24 | 7.3 | +3.0 |
IEMG | iShares Core MSCI Emerging Markets ETF | 0.0 | 9 | 56 | 7.5 | +3.2 |
LDEM | iShares ESG MSCI EM Leaders ETF | 0.0 | 17 | 48 | 7.8 | +3.5 |
EEM | iShares MSCI Emerging Markets ETF | 0.0 | 69 | -4 | 7.0 | +2.7 |
DGS | WisdomTree Emerging Markets SmallCap Dividend Fund | 0.0 | 58 | 7 | 10.2 | +5.8 |
SPGM | SPDR Portfolio MSCI Global Stock Market ETF | 0.0 | 9 | 56 | 5.7 | +1.4 |
DFAX | Dimensional World ex U.S. Core Equity 2 ETF | 0.0 | 30 | 35 | 7.8 | +3.5 |
CWI | SPDR MSCI ACWI ex-US ETF | 0.0 | 30 | 35 | 6.8 | +2.5 |
GSEE | Goldman Sachs MarketBeta Emerging Markets Equity ETF | 0.0 | 36 | 29 | 7.5 | +3.2 |
VSGX | Vanguard ESG International Stock ETF | 0.0 | 12 | 53 | 6.8 | +2.5 |
DBEM | Xtrackers MSCI Emerging Markets Hedged Equity ETF | 0.0 | 66 | -1 | 7.2 | +2.9 |
VXUS | Vanguard Total International Stock ETF | 0.0 | 7 | 58 | 7.1 | +2.8 |
VEU | Vanguard FTSE All-World ex-US Index Fund | 0.0 | 8 | 57 | 7.2 | +2.9 |
FLAX | Franklin FTSE Asia Ex Japan ETF | 0.0 | 19 | 46 | 7.2 | +2.9 |
CRBN | iShares MSCI ACWI Low Carbon Target ETF | 0.0 | 20 | 45 | 5.6 | +1.3 |
VT | Vanguard Total World Stock ETF | 0.0 | 7 | 58 | 5.8 | +1.5 |
ASHR | Xtrackers Harvest CSI 300 China A-Shares ETF | 0.0 | 65 | 0 | 8.9 | +4.6 |
1Overlap is the percentage of holdings by weight that are identical. For example, if Fund A has a 2% position in Apple, Inc. (AAPL) and Fund B has a 5% position, their overlapping position in AAPL is 2%.
Content on this tab for subscribers only**
RESULTS & ESTIMATES
2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | |
---|---|---|---|---|---|---|---|
Sales per share | ** | ** | ** | ** | ** | ** | ** |
Earnings per share | ** | ** | ** | ** | ** | ** | ** |
Dividends per share | ** | ** | ** | ** | ** | ** | ** |
Book value per share | ** | ** | ** | ** | ** | ** | ** |
Sales per share growth | **% | **% | **% | **% | **% | **% | |
EPS growth | **% | **% | **% | **% | **% | **% |
Sales per share growth | **% | **% | **% | **% | **% | **% | |
EPS growth | **% | **% | **% | **% | **% | **% |
OTHER FUNDAMENTAL METRICS
Long term EPS growth est. | **% | Debt-to-equity | **x | |
Asset turnover | **% | Assets-to-equity | **x |
*Six months ago = 100 |
Content on this tab for subscribers only
VALUATION METRICS
2023 | 2024E | 2025E | |
---|---|---|---|
Price-to-sales | ** | ** | ** |
Price-to-earnings | ** | ** | ** |
Price-to-cash flow | ** | ** | ** |
Price-to-growth | ** | ** | ** |
Price-to-book value | ** | ** | ** |
Yield | ** | ** | ** |
Historical valuation trends
Forward multiple: |
VanEck ChiNext ETF | |||
Relative to: |
S&P500 | MSCI EAFE | MSCI Emg. Mkts. | Other ETF: |
AVOID |
Not worthwhile for most investors. A rating of AVOID is assigned to ETFs with ALTAR Scores in the lowest quintile (the bottom 20%) of their category. Often, funds in this category consist of stocks with little if any history or expectation of profitability, and as a result our fundamentally-driven analysis may not be relevant. |
ALTAR Score™
|
MODERN PORTFOLIO THEORY
|
CONSENSUS RECOMMENDATIONS: FUND CONSTITUENTS
|